GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Shiller PE Ratio

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aoxing Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Shiller PE Ratio Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Aoxing Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxing Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Shiller PE Ratio falls into.



Aoxing Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Aoxing Pharmaceutical Co's E10 for the quarter that ended in Mar. 2017 is calculated as:

For example, Aoxing Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2017 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2017 (Change)*Current CPI (Mar. 2017)
=0.002/102.8622*102.8622
=0.002

Current CPI (Mar. 2017) = 102.8622.

Aoxing Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200706 -0.640 87.906 -0.749
200709 0.080 87.964 0.094
200712 -0.060 88.616 -0.070
200803 -0.120 90.090 -0.137
200806 0.210 92.320 0.234
200809 0.016 92.307 0.018
200812 -0.040 88.697 -0.046
200903 0.000 89.744 0.000
200906 -0.020 91.003 -0.023
200909 -0.050 91.120 -0.056
200912 0.060 91.111 0.068
201003 0.000 91.821 0.000
201006 -0.090 91.962 -0.101
201009 -0.010 92.162 -0.011
201012 0.000 92.474 0.000
201103 -0.010 94.283 -0.011
201106 -0.130 95.235 -0.140
201109 -0.020 95.727 -0.021
201112 -0.010 95.213 -0.011
201203 -0.010 96.783 -0.011
201206 -0.280 96.819 -0.297
201209 -0.010 97.633 -0.011
201212 -0.060 96.871 -0.064
201303 -0.050 98.209 -0.052
201306 -0.220 98.518 -0.230
201309 -0.040 98.790 -0.042
201312 -0.040 98.326 -0.042
201403 -0.040 99.695 -0.041
201406 -0.040 100.560 -0.041
201409 0.000 100.428 0.000
201412 0.010 99.070 0.010
201503 0.010 99.621 0.010
201506 0.070 100.684 0.072
201509 0.020 100.392 0.020
201512 0.030 99.792 0.031
201603 0.010 100.470 0.010
201606 -0.020 101.688 -0.020
201609 0.005 101.861 0.005
201612 -0.001 101.863 -0.001
201703 0.002 102.862 0.002

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Aoxing Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines